Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2305 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

IntelGenx and Cary file NDA for depression drug

IntelGenx and Cary Pharma have previously entered into a collaborative agreement to jointly develop and commercialize CPI-300 using IntelGenx’s oral delivery technology. Under the terms of the collaborative

Sunquest and UPMC expand partnership

As part of the agreement, University of Pittsburgh Medical Center (UPMC) will extend the Sunquest system, already in 15 of its 20 hospitals, to additional sites. Additionally, after

Uluru to acquire York Pharma

One of the conditions to Uluru making any offer is that the outstanding debt of York shall be converted into ordinary shares of York prior to the closing